September - 2020

top of page

A L T I T U D E

Nutcracker Therapeutics Announces $60 Million Series B Financing

Emeryville, Calif. – September 23, 2020 Financing led by ARCH Venture Partners Company aims to efficiently develop, manufacture and...

Escient Pharmaceuticals Raises $77.5 Million Series B Round and Initiates a Phase 1/1b Clinical Tria

Proceeds support clinical development for lead program in cholestatic and uremic pruritus and second program for mast cell-related...

bottom of page